Health and FitnessHealth and Fitness
Tue, February 22, 2011
[ Tue, Feb 22nd 2011 ] - Market Wire
Additional Gold Tenements
[ Tue, Feb 22nd 2011 ] - Market Wire
00 P.M. EST
[ Tue, Feb 22nd 2011 ] - Market Wire
Rainy Day Accounts Run Dry

Synta to Participate in Panel Titled Targeting Key Pathways in Cancer at the RBC Capital Markets Healthcare Conference


Published on 2011-02-22 04:35:40 - Market Wire
  Print publication without navigation


LEXINGTON, Mass.--([ BUSINESS WIRE ])--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that President and CEO Safi Bahcall, Ph.D., will participate in a panel discussion titled Targeting Key Pathways in Cancer at the RBC Capital Markets Healthcare Conference on Thursday, March 3 at 10:00 am (ET) in New York.

A live audio webcast and replay of the panel will be available on the "Investors" section of the Company's website, [ www.syntapharma.com ].

About Synta Pharmaceuticals

Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. Synta has a unique chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical- and preclinical-stage drug candidates with distinct mechanisms of action and novel chemical structures. All Synta drug candidates were invented by Synta scientists using our compound library and discovery capabilities. For more information, please visit [ www.syntapharma.com ].